title: FDA's first active medical product surveillance eyes antidiabetic-MI link.
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D000218:Adamantane / Q000009:adverse effects / Q000031:analogs & derivatives; D004151:Dipeptides / Q000009:adverse effects; D017277:Drug Approval / Q000379:methods*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000175:diagnosis; D011358:Product Surveillance, Postmarketing / Q000379:methods* / Q000639:trends; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration / Q000639:trends
chemical_list: D004151:Dipeptides; D007004:Hypoglycemic Agents; C502994:saxagliptin; D000218:Adamantane